IMNN
Imunon, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Stacy R. Lindborg
IPO Date
1999-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Imunon, Inc.
CEO
Stacy R. Lindborg
IPO Date
1999-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 5,557 |
| $2.20 |
| 27 May 2026 | Dentzer James E | director | A-Award | Acquired | 11,148 | $2.20 |
| 27 May 2026 | Braun Donald P | director | A-Award | Acquired | 5,011 | $2.20 |
| 27 May 2026 | Fritz Frederick J. | director | A-Award | Acquired | 10,330 | $2.20 |
| 27 May 2026 | Lindborg Stacy | director, officer: President and CEO | A-Award | Acquired | 1,491 | $2.20 |
| 20 Jan 2026 | CHURCH JEFFREY WAYNE | CFO | Disposed | 5,000 | $3.95 |
| 20 Jan 2026 | CHURCH JEFFREY WAYNE | CFO | Disposed | 0 | $0.00 |
| 20 Jan 2026 | CHURCH JEFFREY WAYNE | CFO | Disposed | 167 | $9.20 |
| 6 Jan 2026 | Bragg Kimberly | CFO | A-Award | Acquired | 9,050 | $3.95 |